Human mast cells derived from fetal liver cells cultured with stem cell factor express a functional CD51/CD61 (alpha v beta 3) integrin.
Human fetal livers contain progenitor cells that become mast cells after 4 weeks of culture with recombinant human stem cell factor. Expression of cell surface CD29 (beta 1), CD18 (beta 2), CD61 (beta 3), and beta 5 integrins was investigated on such cells by flow cytometry and adhesion measurements. High surface expression of CD49e, CD51, and CD61 along with kit was apparent by 4 weeks of culture, whereas expression of each at day 0 was low to undetectable. CD29 and CD49d were detected on cells from day 0 to 4 weeks of culture; CD49b, CD49c, CD49f, CD18, and CD54 expression was negligible. The fetal liver-derived mast cells spontaneously adhered to vitronectin. No evidence for degranulation was found during vitronectin-dependent adhesion. Adhesion occurred in part through the CD61/CD51 receptor. No evidence for adhesion to vitronectin through CD29 and beta 5 integrins was obtained. Almost all of the vitronectin-adherent cells expressed CD51, CD61, kit, and tryptase, and exhibited metachromasia with toluidine blue. Thus, among the fetal liver-derived cells, developing mast cells were selectively adherent to vitronectin. These mast cells and the other cell types present also adhere spontaneously to fibronectin and to laminin, this adhesion being partially inhibited by antibodies against CD61 and CD29 integrins. In conclusion, human mast cells acquire functional vitronectin receptors as they develop from fetal liver progenitors under the influence of rhSCF. This may be important for the recruitment, localization, and retention of developing mast cells.
Shimizu
Y
Y
Department of Internal Medicine, Virginia Commonwealth University, Richmond, USA.
Irani
A M
AM
Brown
E J
EJ
Ashman
L K
LK
Schwartz
L B
LB
D000595:Amino Acid Sequence; D015703:Antigens, CD / Q000378:metabolism; D002413:Cations, Divalent; D002448:Cell Adhesion; D002478:Cells, Cultured; D005353:Fibronectins / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D039564:Integrin alphaV; D039661:Integrin beta3; D016023:Integrins / Q000378:metabolism*; D007797:Laminin / Q000378:metabolism; D008099:Liver / Q000196:embryology*; D008407:Mast Cells / Q000166:cytology*; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000737:chemistry / Q000378:metabolism; D016024:Receptors, Cytoadhesin / Q000378:metabolism*; D019030:Receptors, Vitronectin; D019089:Stem Cell Factor; D019096:Vitronectin
D015703:Antigens, CD; D002413:Cations, Divalent; D005353:Fibronectins; D006023:Glycoproteins; D016298:Hematopoietic Cell Growth Factors; D039564:Integrin alphaV; D039661:Integrin beta3; D016023:Integrins; D007797:Laminin; D009842:Oligopeptides; D016024:Receptors, Cytoadhesin; D019030:Receptors, Vitronectin; D019089:Stem Cell Factor; D019096:Vitronectin; C047981:arginyl-glycyl-aspartic acid